• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类巨细胞病毒的I类主要组织相容性复合体同源物可抑制自然杀伤细胞的攻击。

The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.

作者信息

Reyburn H T, Mandelboim O, Valés-Gómez M, Davis D M, Pazmany L, Strominger J L

机构信息

Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA.

出版信息

Nature. 1997 Apr 3;386(6624):514-7. doi: 10.1038/386514a0.

DOI:10.1038/386514a0
PMID:9087413
Abstract

Recognition and destruction of virus-infected cells by class I major histocompatibility complex (MHC) restricted cytotoxic T lymphocytes (CTL) is a central part of the immune system's attempts to control and eliminate virus infection. It is therefore not surprising that many viruses have evolved strategies to interfere with the processing and presentation of peptide antigen on class I MHC molecules (reviewed in ref. 1). These mechanisms act to prevent or reduce expression of MHC molecules at the cell surface. However, many natural killer (NK) cells are able to recognize and destroy host cells that no longer express class I MHC molecules (the 'missing self' hypothesis). Thus, any virus-infected cell that has lost cell-surface expression of MHC class I to avoid CTL attack should become susceptible to NK-cell-mediated destruction. We describe here the first example, to our knowledge, of a viral strategy to evade immune surveillance by NK cells.

摘要

I类主要组织相容性复合体(MHC)限制的细胞毒性T淋巴细胞(CTL)对病毒感染细胞的识别与破坏,是免疫系统控制和消除病毒感染努力的核心部分。因此,许多病毒已进化出干扰I类MHC分子上肽抗原加工与呈递的策略也就不足为奇了(参考文献1中有综述)。这些机制会阻止或减少MHC分子在细胞表面的表达。然而,许多自然杀伤(NK)细胞能够识别并破坏不再表达I类MHC分子的宿主细胞(“缺失自我”假说)。因此,任何为避免CTL攻击而失去I类MHC细胞表面表达的病毒感染细胞,都应易受NK细胞介导的破坏。据我们所知,我们在此描述了首个病毒逃避NK细胞免疫监视策略的例子。

相似文献

1
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.人类巨细胞病毒的I类主要组织相容性复合体同源物可抑制自然杀伤细胞的攻击。
Nature. 1997 Apr 3;386(6624):514-7. doi: 10.1038/386514a0.
2
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.巨细胞病毒MHC I类同源物在体内对自然杀伤细胞的抑制作用。
Nature. 1997 Apr 3;386(6624):510-4. doi: 10.1038/386510a0.
3
Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.鼠巨细胞病毒编码的I类主要组织相容性复合体同源物m144对自然杀伤细胞的抑制作用。
Cell Immunol. 1999 Feb 1;191(2):145-51. doi: 10.1006/cimm.1998.1424.
4
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.
5
The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.CD94/NKG2-A抑制性受体复合物参与自然杀伤细胞介导的对表达HLA-G1细胞的识别。
J Immunol. 1997 Jun 15;158(12):5736-43.
6
Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.巨细胞病毒感染中主要组织相容性复合体I类及相关分子的自然杀伤细胞受体
Tissue Antigens. 2004 Mar;63(3):195-203. doi: 10.1111/j.1399-0039.2004.00210.x.
7
UL40-mediated NK evasion during productive infection with human cytomegalovirus.人巨细胞病毒有效感染期间UL40介导的自然杀伤细胞逃逸
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5. doi: 10.1073/pnas.112680099.
8
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.激活型和抑制型自然杀伤细胞受体对巨细胞病毒的直接识别。
Science. 2002 May 17;296(5571):1323-6. doi: 10.1126/science.1070884. Epub 2002 Apr 11.
9
Natural killer cell recognition of HLA class I molecules.自然杀伤细胞对HLA I类分子的识别。
Rev Immunogenet. 2000;2(3):433-48.
10
Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients.人类免疫缺陷病毒(HIV)感染/艾滋病(AIDS)患者中,MHC I类分子结合性自然杀伤细胞受体的表达调控以及与病毒载量相关的自然杀伤细胞活性
J Med Virol. 2001 Nov;65(3):431-40.

引用本文的文献

1
Why Are Cytomegalovirus-Encoded G-Protein-Coupled Receptors Essential for Infection but Only Variably Conserved?为何巨细胞病毒编码的G蛋白偶联受体对感染至关重要但保守性却存在差异?
Pathogens. 2025 Mar 3;14(3):245. doi: 10.3390/pathogens14030245.
2
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.靶向 LILRB1 在癌症固有和适应性免疫检查点治疗中的研究进展。
Front Immunol. 2023 Sep 13;14:1240275. doi: 10.3389/fimmu.2023.1240275. eCollection 2023.
3
Insights into the Transcriptome of Human Cytomegalovirus: A Comprehensive Review.
人类巨细胞病毒转录组的研究进展:全面综述。
Viruses. 2023 Aug 8;15(8):1703. doi: 10.3390/v15081703.
4
Strategies to induce natural killer cell tolerance in xenotransplantation.在异种移植中诱导自然杀伤细胞耐受的策略。
Front Immunol. 2022 Aug 22;13:941880. doi: 10.3389/fimmu.2022.941880. eCollection 2022.
5
SARS-CoV-2 Omicron variant: Immune escape and vaccine development.严重急性呼吸综合征冠状病毒2型奥密克戎变种:免疫逃逸与疫苗研发
MedComm (2020). 2022 Mar 16;3(1):e126. doi: 10.1002/mco2.126. eCollection 2022 Mar.
6
Editorial: Infectious Agent-Induced Chronic Immune Activation: Causes, Phenotypes, and Consequences.社论:感染因子诱导的慢性免疫激活:原因、表型及后果
Front Immunol. 2021 Dec 10;12:740556. doi: 10.3389/fimmu.2021.740556. eCollection 2021.
7
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.白细胞免疫球蛋白样受体B亚家族:癌症中的治疗靶点
Antib Ther. 2021 Feb 9;4(1):16-33. doi: 10.1093/abt/tbab002. eCollection 2021 Jan.
8
Cure My Virus: Hematemesis and Melena in a Transplant Recipient.治愈我的病毒:一名移植受者的呕血和黑便
Dig Dis Sci. 2021 Mar;66(3):728-732. doi: 10.1007/s10620-021-06838-1. Epub 2021 Feb 2.
9
Regional Injection of CAR-T Cells for the Treatment of Refractory and Recurrent Diffuse Large B Cell Lymphoma: A Case Report.局部注射嵌合抗原受体T细胞治疗难治性复发性弥漫性大B细胞淋巴瘤:病例报告
Front Cell Dev Biol. 2020 May 8;8:333. doi: 10.3389/fcell.2020.00333. eCollection 2020.
10
Battle between Host Immune Cellular Responses and HCMV Immune Evasion.宿主免疫细胞应答与 HCMV 免疫逃逸的较量。
Int J Mol Sci. 2019 Jul 24;20(15):3626. doi: 10.3390/ijms20153626.